(Q33490023)
Statements
1 reference
Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724). (English)
1 reference
Nelson RL
1 reference
Creaven PJ
1 reference
Cohen MH
1 reference
Fossieck BE Jr
1 reference
1 reference
Identifiers
1 reference